ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$127,847 | -$100,697 | -$89,122 | -$78,715 |
| Dep. & Amort. | $1,107 | $1,032 | $966 | $897 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $20,213 | $15,226 | $14,460 | $12,853 |
| Change in WC | $1,968 | $4,898 | -$445 | $4,073 |
| Other Non-Cash | -$8,103 | -$6,147 | -$1,002 | $1,351 |
| Operating Cash Flow | -$112,662 | -$85,688 | -$75,143 | -$59,541 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,188 | -$849 | -$2,078 | -$939 |
| Net Acquisitions | $0 | $0 | $2,078 | $1,375 |
| Inv. Purchases | -$251,920 | -$239,244 | -$238,124 | -$69,626 |
| Inv. Sales/Matur. | $275,245 | $196,690 | $130,954 | $229,000 |
| Other Inv. Act. | $0 | $0 | -$2,078 | -$1,375 |
| Investing Cash Flow | $22,137 | -$43,403 | -$109,248 | $158,435 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $125,000 | $85,000 | $25,000 | $50,000 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,547 | $658 | $225 | -$866 |
| Financing Cash Flow | $126,547 | $85,658 | $25,225 | $49,134 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $36,022 | -$43,433 | -$159,166 | $148,028 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23,875 | $67,308 | $226,474 | $78,446 |
| End Cash | $59,897 | $23,875 | $67,308 | $226,474 |
| Free Cash Flow | -$113,850 | -$86,537 | -$77,221 | -$60,480 |